Thereafter, testosterone gradually increases to high levels with the development of the adult Leydig cells from stem cells of the neonatal testis. In the adult, luteinizing hormone (LH) binding to Leydig cell LH receptors stimulates cAMP production, increasing the rate of cholesterol translocation into the mitochondria. Leydig cells release a class of hormones called androgens (19-carbon steroids). A combination of growth factors and hormones during puberty (LH, T3, IGF-1, PDGF-α) trigger the progenitor cells to transition into immature Leydig cells, which are elongated and express high levels of steroidogenic enzymes. The testes make hormones like testosterone in the Leydig cells. Total levels of testosterone in the body have been reported as 264 to 916 ng/dL (nanograms per deciliter) in non-obese European and American men age 19 to 39 years, while mean testosterone levels in adult men have been reported as 630 ng/dL. When testosterone levels are low, gonadotropin-releasing hormone (GnRH) is released by the hypothalamus, which in turn stimulates the pituitary gland to release FSH and LH. Steroidogenic acute regulatory protein acts at this complex to enhance cholesterol movement across the membranes and thus increase testosterone formation. Testosterone then gradually increases to high levels with adult Leydig cell development from stem cells. Fetal-type Leydig cells are present from the 8th to the 20th week of gestation, which produce enough testosterone for masculinisation of a male fetus. Leydig cells, also known as interstitial cells of the testes and interstitial cells of Leydig, are found adjacent to the seminiferous tubules in the testicle and produce testosterone in the presence of luteinizing hormone (LH). Agnathans (jawless vertebrates) such as lampreys do not produce testosterone but instead use androstenedione as a male sex hormone. Like other androsteroids, testosterone is manufactured industrially from microbial fermentation of plant cholesterol (e.g., from soybean oil). In women with hyperandrogenism, mean levels of total testosterone have been reported to be 62.1 ng/dL. The T-receptor or DHT-receptor complex undergoes a structural change that allows it to move into the cell nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. Both the free fraction and the one bound to albumin are available at the tissue level (their sum constitutes the bioavailable testosterone), while SHBG effectively and irreversibly inhibits the action of testosterone. At the tissue level, testosterone dissociates from albumin and quickly diffuses into the tissues. This binding plays an important role in regulating the transport, tissue delivery, bioactivity, and metabolism of testosterone. As a result, testosterone which is not bound to SHBG is called free testosterone. Fairer offers from test subjects with higher testosterone in the original study increase the likeliness of the offer being accepted by the negotiating partner, therefore decreasing the probability of both participants leaving without any money. However men with high testosterone were significantly 27% less generous in an ultimatum game. Testosterone can be described as having anabolic and androgenic (virilising) effects, though these categorical descriptions are somewhat arbitrary, as there is a great deal of mutual overlap between them. In addition to its role as a natural hormone, testosterone is used as a medication to treat hypogonadism and breast cancer. In humans and most other vertebrates, testosterone is secreted primarily by the testicles of males and, to a lesser extent, the ovaries of females. Testosterone is a steroid hormone from the androstane class containing a ketone and a hydroxyl group at positions three and seventeen respectively. Another promising possible approach to increasing serum testosterone in hypogonadal men might be to target γ and/or ɛ, negative regulators of testosterone production. Thus, ligand activated TSPO might reestablish normal TSPO activity and be responsible for the recovery of testosterone formation perhaps in a testis-specific manner. It should be noted however that in aging rats, Leydig cell TSPO levels are reduced by 50% . In 1980, Mather developed the TM3 mouse cell line believed to be derived from immature Leydig cells . In 1968, Sato and colleagues developed the R2C rat tumor Leydig cell line that produced progesterone in a constitutive, hormone-independent, manner . Attempts to generate androgen-producing Leydig cell lines have been met with limited success. Later studies indicated that though LH is required to maintain Leydig cell structure, it is not required to maintain Leydig cell number . These results suggested that LH regulates not only Leydig cell steroidogenesis but also Leydig cell ultrastructure. However, recent studies suggest that there may be increased risk of cardiovascular disease in older men after TRT 115–117, resulting in the FDA cautioning (September 2014) that men who take exogenous testosterone may face increased risk of stroke and heart attack. However, hypogonadism in most patients is not the result of central deficiencies, but rather results from the decreased responsiveness of the Leydig cells to LH. Reduced serum levels of testosterone (hypogonadism) can occur in both young and aging men. Steroid hormone synthesis must be a precisely regulated process because insufficient or excess production is detrimental. Such differences might result from differences in the amounts of the transduceosome components and cell-specific protein–protein interactions.
